APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neurothrombectomy Devices

A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to retrieve or destroy blood clots in the cerebral neurovasculature.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to retrieve or destroy blood clots in the cerebral neurovasculature.

Selected research

Market Outlook & Growth Opportunities

Global Neurothrombectomy Devices Market Outlook and Growth Opportunities 2026

Report ID 17331694049 January 2026190 pages

Choose your research edition.

Industry ResearchNeurothrombectomy Devices Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurothrombectomy Devices Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Neurothrombectomy Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurothrombectomy Devices Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurothrombectomy Devices Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to retrieve or destroy blood clots in the cerebral neurovasculature.

In Europe, Neurothrombectomy Devices key players include Stryker, etc. Europe top one manufacturer hold a share over 25%. Germany is the largest market, with a share over 15%.

In terms of product, Retriever is the largest segment, with a share over 90%. And in terms of application, the largest application is Hospitals, followed by Clinics.

Read the full market overview

This report provides an overview of the global Neurothrombectomy Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurothrombectomy Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurothrombectomy Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurothrombectomy Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurothrombectomy Devices Segment by Company

Stryker

Medtronic

Penumbra

Phenox

Acandis GmbH

Neurothrombectomy Devices Segment by Type

Retriever

Integrated System

Neurothrombectomy Devices Segment by Application

Hospitals

Clinics

Others

Neurothrombectomy Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neurothrombectomy Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neurothrombectomy Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neurothrombectomy Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Neurothrombectomy Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurothrombectomy Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurothrombectomy Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurothrombectomy Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurothrombectomy Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurothrombectomy Devices industry.

Chapter 3: Detailed analysis of Neurothrombectomy Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neurothrombectomy Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neurothrombectomy Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neurothrombectomy Devices Industry Trends Table 2. Neurothrombectomy Devices Industry Drivers Table 3. Neurothrombectomy Devices Industry Opportunities and Challenges Table 4. Neurothrombectomy Devices Industry Restraints Table 5. Global Neurothrombectomy Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neurothrombectomy Devices Revenue Share by Company (2021-2026) Table 7. Global Neurothrombectomy Devices Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Neurothrombectomy Devices Sales Volume Share by Company (2021-2026) Table 9. Global Neurothrombectomy Devices Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Neurothrombectomy Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Neurothrombectomy Devices Key Company Manufacturing Base & Headquarters Table 12. Global Neurothrombectomy Devices Company, Product Type & Application Table 13. Global Neurothrombectomy Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurothrombectomy Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Retriever Table 18. Significant Companies of Integrated System Table 19. Global Neurothrombectomy Devices Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Neurothrombectomy Devices Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Neurothrombectomy Devices Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Neurothrombectomy Devices Sales Volume Share by Type (2021-2026) Table 23. Global Neurothrombectomy Devices Sales Volume Share by Type (2027-2032) Table 24. Global Neurothrombectomy Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Neurothrombectomy Devices Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Neurothrombectomy Devices Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Neurothrombectomy Devices Sales Value Share by Type (2021-2026) Table 28. Global Neurothrombectomy Devices Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Clinics Table 31. Significant Companies of Others Table 32. Global Neurothrombectomy Devices Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Neurothrombectomy Devices Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Neurothrombectomy Devices Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Neurothrombectomy Devices Sales Volume Share by Application (2021-2026) Table 36. Global Neurothrombectomy Devices Sales Volume Share by Application (2027-2032) Table 37. Global Neurothrombectomy Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Neurothrombectomy Devices Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Neurothrombectomy Devices Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Neurothrombectomy Devices Sales Value Share by Application (2021-2026) Table 41. Global Neurothrombectomy Devices Sales Value Share by Application (2027-2032) Table 42. Global Neurothrombectomy Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Neurothrombectomy Devices Sales by Region (2021-2026) & (K Units) Table 44. Global Neurothrombectomy Devices Sales Market Share by Region (2021-2026) Table 45. Global Neurothrombectomy Devices Sales by Region (2027-2032) & (K Units) Table 46. Global Neurothrombectomy Devices Sales Market Share by Region (2027-2032) Table 47. Global Neurothrombectomy Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Neurothrombectomy Devices Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Neurothrombectomy Devices Sales Value Share by Region (2021-2026) Table 50. Global Neurothrombectomy Devices Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Neurothrombectomy Devices Sales Value Share by Region (2027-2032) Table 52. Global Neurothrombectomy Devices Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Neurothrombectomy Devices Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Neurothrombectomy Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Neurothrombectomy Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Neurothrombectomy Devices Sales by Country (2021-2026) & (K Units) Table 57. Global Neurothrombectomy Devices Sales Market Share by Country (2021-2026) Table 58. Global Neurothrombectomy Devices Sales by Country (2027-2032) & (K Units) Table 59. Global Neurothrombectomy Devices Sales Market Share by Country (2027-2032) Table 60. Global Neurothrombectomy Devices Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Neurothrombectomy Devices Sales Value Market Share by Country (2021-2026) Table 62. Global Neurothrombectomy Devices Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Neurothrombectomy Devices Sales Value Market Share by Country (2027-2032) Table 64. Stryker Company Information Table 65. Stryker Business Overview Table 66. Stryker Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Stryker Neurothrombectomy Devices Product Portfolio Table 68. Stryker Recent Development Table 69. Medtronic Company Information Table 70. Medtronic Business Overview Table 71. Medtronic Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Medtronic Neurothrombectomy Devices Product Portfolio Table 73. Medtronic Recent Development Table 74. Penumbra Company Information Table 75. Penumbra Business Overview Table 76. Penumbra Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Penumbra Neurothrombectomy Devices Product Portfolio Table 78. Penumbra Recent Development Table 79. Phenox Company Information Table 80. Phenox Business Overview Table 81. Phenox Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Phenox Neurothrombectomy Devices Product Portfolio Table 83. Phenox Recent Development Table 84. Acandis GmbH Company Information Table 85. Acandis GmbH Business Overview Table 86. Acandis GmbH Neurothrombectomy Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Acandis GmbH Neurothrombectomy Devices Product Portfolio Table 88. Acandis GmbH Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Neurothrombectomy Devices Distributors List Table 92. Neurothrombectomy Devices Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Neurothrombectomy Devices Product Image Figure 2. Global Neurothrombectomy Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurothrombectomy Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Neurothrombectomy Devices Sales (2021-2032) & (K Units) Figure 5. Global Neurothrombectomy Devices Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Neurothrombectomy Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Retriever Image Figure 10. Integrated System Image Figure 11. Global Neurothrombectomy Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Neurothrombectomy Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Neurothrombectomy Devices Sales Volume Share by Type (2021-2032) Figure 14. Global Neurothrombectomy Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Neurothrombectomy Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Neurothrombectomy Devices Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Neurothrombectomy Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Neurothrombectomy Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Neurothrombectomy Devices Sales Volume Share by Application (2021-2032) Figure 23. Global Neurothrombectomy Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Neurothrombectomy Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Neurothrombectomy Devices Sales Value Share by Application (2021-2032) Figure 26. Global Neurothrombectomy Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Neurothrombectomy Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Neurothrombectomy Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Neurothrombectomy Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Neurothrombectomy Devices Sales Value (2021-2032) & (US$ Million) Figure 31. North America Neurothrombectomy Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Neurothrombectomy Devices Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Neurothrombectomy Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Neurothrombectomy Devices Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Neurothrombectomy Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Neurothrombectomy Devices Sales Value (2021-2032) & (US$ Million) Figure 37. South America Neurothrombectomy Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Neurothrombectomy Devices Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Neurothrombectomy Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Neurothrombectomy Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Neurothrombectomy Devices Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Neurothrombectomy Devices Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Retriever
  • Integrated System
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Stryker
  • Medtronic
  • Penumbra
  • Phenox
  • Acandis GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurothrombectomy Devices Sales Value (2021-2032)
  4. 1.2.2 Global Neurothrombectomy Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Neurothrombectomy Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Neurothrombectomy Devices Market Dynamics
  1. 2.1 Neurothrombectomy Devices Industry Trends
  2. 2.2 Neurothrombectomy Devices Industry Drivers
  3. 2.3 Neurothrombectomy Devices Industry Opportunities and Challenges
  4. 2.4 Neurothrombectomy Devices Industry Restraints
3 Neurothrombectomy Devices Market by Company
  1. 3.1 Global Neurothrombectomy Devices Company Revenue Ranking in 2025
  2. 3.2 Global Neurothrombectomy Devices Revenue by Company (2021-2026)
  3. 3.3 Global Neurothrombectomy Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Neurothrombectomy Devices Average Price by Company (2021-2026)
  5. 3.5 Global Neurothrombectomy Devices Company Ranking (2024-2026)
  6. 3.6 Global Neurothrombectomy Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Neurothrombectomy Devices Company Product Type and Application
  8. 3.8 Global Neurothrombectomy Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Neurothrombectomy Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Neurothrombectomy Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Neurothrombectomy Devices Market by Type
  1. 4.1 Neurothrombectomy Devices Type Introduction
  2. 4.1.1 Retriever
  3. 4.1.2 Integrated System
  4. 4.2 Global Neurothrombectomy Devices Sales Volume by Type
  5. 4.2.1 Global Neurothrombectomy Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Neurothrombectomy Devices Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Neurothrombectomy Devices Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Neurothrombectomy Devices Sales Value by Type
  9. 4.3.1 Global Neurothrombectomy Devices Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Neurothrombectomy Devices Sales Value by Type (2021-2032)
  11. 4.3.3 Global Neurothrombectomy Devices Sales Value Share by Type (2021-2032)
5 Neurothrombectomy Devices Market by Application
  1. 5.1 Neurothrombectomy Devices Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Neurothrombectomy Devices Sales Volume by Application
  6. 5.2.1 Global Neurothrombectomy Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurothrombectomy Devices Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Neurothrombectomy Devices Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Neurothrombectomy Devices Sales Value by Application
  10. 5.3.1 Global Neurothrombectomy Devices Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neurothrombectomy Devices Sales Value by Application (2021-2032)
  12. 5.3.3 Global Neurothrombectomy Devices Sales Value Share by Application (2021-2032)
6 Neurothrombectomy Devices Regional Sales and Value Analysis
  1. 6.1 Global Neurothrombectomy Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurothrombectomy Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Neurothrombectomy Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Neurothrombectomy Devices Sales by Region (2027-2032)
  5. 6.3 Global Neurothrombectomy Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Neurothrombectomy Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Neurothrombectomy Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Neurothrombectomy Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Neurothrombectomy Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Neurothrombectomy Devices Sales Value (2021-2032)
  12. 6.6.2 North America Neurothrombectomy Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Neurothrombectomy Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Neurothrombectomy Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Neurothrombectomy Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Neurothrombectomy Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Neurothrombectomy Devices Sales Value (2021-2032)
  21. 6.9.2 South America Neurothrombectomy Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Neurothrombectomy Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Neurothrombectomy Devices Sales Value Share by Country, 2025 VS 2032
7 Neurothrombectomy Devices Country-level Sales and Value Analysis
  1. 7.1 Global Neurothrombectomy Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neurothrombectomy Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Neurothrombectomy Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Neurothrombectomy Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Neurothrombectomy Devices Sales by Country (2027-2032)
  6. 7.4 Global Neurothrombectomy Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Neurothrombectomy Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Neurothrombectomy Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Neurothrombectomy Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Neurothrombectomy Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Neurothrombectomy Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Stryker
  2. 8.1.1 Stryker Company Information
  3. 8.1.2 Stryker Business Overview
  4. 8.1.3 Stryker Neurothrombectomy Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Stryker Neurothrombectomy Devices Product Portfolio
  6. 8.1.5 Stryker Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Neurothrombectomy Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Neurothrombectomy Devices Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 Penumbra
  14. 8.3.1 Penumbra Company Information
  15. 8.3.2 Penumbra Business Overview
  16. 8.3.3 Penumbra Neurothrombectomy Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Penumbra Neurothrombectomy Devices Product Portfolio
  18. 8.3.5 Penumbra Recent Developments
  19. 8.4 Phenox
  20. 8.4.1 Phenox Company Information
  21. 8.4.2 Phenox Business Overview
  22. 8.4.3 Phenox Neurothrombectomy Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Phenox Neurothrombectomy Devices Product Portfolio
  24. 8.4.5 Phenox Recent Developments
  25. 8.5 Acandis GmbH
  26. 8.5.1 Acandis GmbH Company Information
  27. 8.5.2 Acandis GmbH Business Overview
  28. 8.5.3 Acandis GmbH Neurothrombectomy Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Acandis GmbH Neurothrombectomy Devices Product Portfolio
  30. 8.5.5 Acandis GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurothrombectomy Devices Value Chain Analysis
  2. 9.1.1 Neurothrombectomy Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurothrombectomy Devices Sales Mode & Process
  6. 9.2 Neurothrombectomy Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurothrombectomy Devices Distributors
  9. 9.2.3 Neurothrombectomy Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst